Video Series: Current Topics in the Treatment of Advanced PCa

Targeted Agents

Philip Kantoff, MD, Andrew Armstrong, MD, William Oh, MD, and A. Oliver Sartor, MD, discuss advances in treatment of castration-resistant prostate cancer and metastatic castration-resistant prostate cancer, specifically newer hormonal therapies.

Latest Prostate Cancer Features

Latest Prostate Cancer News

Landmark PSA Screening Trial Results Challenged

Landmark PSA Screening Trial Results Challenged

The PLCO trial's conclusion that routine PSA testing does not affect prostate cancer mortality risk could be wrong.

Study Independently Validates New Prostate Cancer Grading System

Study Independently Validates New Prostate Cancer Grading System

Findings support the use of a 5 grade-group system that more accurately reflects patient risk of adverse outcomes.

PSA Screening More Likely Among Blacks

PSA Screening More Likely Among Blacks

The odds of PSA screening were higher among blacks than non-Hispanic whites.

Fluoroquinolones May Be Unwarranted for High PSA

Fluoroquinolones May Be Unwarranted for High PSA

PSA level declined by an average of 0.68 ng/mL in the treatment group.

Aminosalicylates Cut PCa Risk in Men with IBD

Aminosalicylates Cut PCa Risk in Men with IBD

Researchers found an adjusted 68% decreased risk of prostate cancer in men with IBD who used aminosalicylate.

Psychotherapy-PDE5 Inhibitor Combo Helps Post-RP Erectile Function

Psychotherapy-PDE5 Inhibitor Combo Helps Post-RP Erectile Function

An early, integrated approach led to less deterioration of erectile function after surgery.

Fatty Foods Possibly Contribute to Prostate Cancer Aggressiveness

Fatty Foods Possibly Contribute to Prostate Cancer Aggressiveness

Researchers also suggests that statins may help counteract harmful effect of fatty foods.

Polymer-Delivered Leuprolide Achieves Castration-Level Testosterone

Polymer-Delivered Leuprolide Achieves Castration-Level Testosterone

Testosterone levels of 20 ng/dL or less were achieved and maintained by more than 90% of men with advanced prostate cancer.

Better Prostate Cancer Survival With Low-Dose Aspirin?

Better Prostate Cancer Survival With Low-Dose Aspirin?

Improved odds seen for patients with colon, prostate, or breast tumors, but research isn't definitive.

Possible Biomarkers Identified for PCa Patients Treated With SBRT

Possible Biomarkers Identified for PCa Patients Treated With SBRT

Molecular pathways identified that may serve as potential biomarkers in prostate cancer treated with stereotactic body radiation therapy (SBRT).

Regular Exercise Before PCa Diagnosis May Increase Survival

Regular Exercise Before PCa Diagnosis May Increase Survival

Researchers found that men who exercised the most had the best outcomes.

Metformin Ups Anti-Cancer Activity of Abiraterone, Enzalutamide

Metformin Ups Anti-Cancer Activity of Abiraterone, Enzalutamide

Metformin, a widely used oral anti-diabetic drug, enhanced the anti-prostate cancer activity of abiraterone and enzalutamide.

Prostate Cancer Mortality Declined Along With Cigarette Smoking

Prostate Cancer Mortality Declined Along With Cigarette Smoking

Fewer prostate cancer deaths may be yet another benefit of smoking cessation.

Multiple Comorbidities Predict Higher-Risk Prostate Cancer

Multiple Comorbidities Predict Higher-Risk Prostate Cancer

Prostate cancer patients with 2 or more comorbid diseases are more likely to have their cancer upgraded and up staged at RP.

ADT for Prostate Cancer Linked to Depression

ADT for Prostate Cancer Linked to Depression

Researchers find 23% increased risk compared to men who received other treatments.

Prostate Cancer Videos

Sign up for free e-Newsletters